Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

"Dermatologic Therapy" offers expert treatment info for various skin diseases.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Chronic scalp lesions with crusts and pus indicate Erosive Pustular Dermatosis, which is confirmed by biopsy and effectively treated with strong topical steroids.

MPZL3 is crucial for seborrheic dermatitis development.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Liposomes and niosomes can help drugs penetrate the skin better.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Minoxidil promotes hair growth in male pattern baldness.

Topical sensitizers have mixed success in treating alopecia areata.

Minoxidil can cause skin allergy; use alternative solvents or treatments if allergic.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Topical Ruxolitinib may safely treat severe hair loss.